Lung volumes predict survival in patients with chronic lung allograft dysfunction

被引:35
|
作者
Kneidinger, Nikolaus [1 ]
Milger, Katrin [1 ]
Janitza, Silke [2 ]
Ceelen, Felix [1 ]
Leuschner, Gabriela [1 ]
Dinkel, Julien [3 ]
Koenigshoff, Melanie [4 ]
Weig, Thomas [5 ]
Schramm, Rene [6 ]
Winter, Hauke [7 ]
Behr, Juergen [1 ]
Neurohr, Claus [1 ]
机构
[1] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Dept Internal Med 5, Marchioninistr 15, D-81377 Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Dept Med Informat Biometry & Epidemiol, Munich, Germany
[3] Univ Munich, German Ctr Lung Res DZL, Comprehens Pneumol Ctr CPC M, Inst Clin Radiol, Munich, Germany
[4] German Ctr Lung Res DZL, Helmholtz Zentrum Munchen, Comprehens Pneumol Ctr CPC M, Res Unit Lung Repair & Regenerat, Munich, Germany
[5] Univ Munich, Dept Anaesthesiol, Munich, Germany
[6] Univ Munich, Clin Cardiac Surg, Munich, Germany
[7] Univ Munich, Dept Thorac Surg, Munich, Germany
关键词
BRONCHIOLITIS OBLITERANS SYNDROME; THIN-SECTION CT; COMPUTED-TOMOGRAPHY; RISK-FACTORS; TRANSPLANTATION; HYPERINFLATION; MORTALITY; ONSET;
D O I
10.1183/13993003.01315-2016
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Identification of disease phenotypes might improve the understanding of patients with chronic lung allograft dysfunction (CLAD). The aim of the study was to assess the impact of pulmonary restriction and air trapping by lung volume measurements at the onset of CLAD. A total of 396 bilateral lung transplant recipients were analysed. At onset, CLAD was further categorised based on plethysmography. A restrictive CLAD (R-CLAD) was defined as a loss of total lung capacity from baseline. CLAD with air trapping (AT-CLAD) was defined as an increased ratio of residual volume to total lung capacity. Outcome was survival after CLAD onset. Patients with insufficient clinical information were excluded (n=95). Of 301 lung transplant recipients, 94 (31.2%) developed CLAD. Patients with R-CLAD (n=20) and AT-CLAD (n=21), respectively, had a significantly worse survival (p<0.001) than patients with non-R/AT-CLAD. Both R-CLAD and AT-CLAD were associated with increased mortality when controlling for multiple confounding variables (hazard ratio (HR) 3.57, 95% CI 1.39-9.18; p=0.008; and HR 2.65, 95% CI 1.05-6.68; p=0.039). Furthermore, measurement of lung volumes was useful to identify patients with combined phenotypes. Measurement of lung volumes in the long-term follow-up of lung transplant recipients allows the identification of patients who are at risk for worse outcome and warrant special consideration.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Lung Tissue Telomere Length in Chronic Lung Allograft Dysfunction
    Sacreas, A.
    Lammertyn, E. J.
    Everaerts, S.
    Martens, D. S.
    McDonough, J. E.
    Nawrot, T. S.
    Verleden, G. M.
    Verleden, S. E.
    Vos, R.
    Vanaudenaerde, B. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S444 - S444
  • [32] Changing the curve in chronic lung allograft dysfunction: Implications of chronic lung allograft dysfunction phenotypes in assessing treatment interventions
    Mooney, Joshua J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (03): : 319 - 320
  • [33] A new biomarker for chronic lung allograft dysfunction
    Pain, Mallory
    Royer, Pierre-Joseph
    Loy, Jennifer
    Fieux, Maxime
    Tissot, Adrien
    Lacoste, Philippe
    Reboulleau, Damien
    Pares, Sandie
    Botturi, Karine
    Magnan, Antoine
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [34] Infectious Triggers of Chronic Lung Allograft Dysfunction
    Aric L. Gregson
    Current Infectious Disease Reports, 2016, 18
  • [35] Alemtuzumab For The Treatment Of Chronic Lung Allograft Dysfunction
    Owen, D.
    Lushin, E.
    Gutteridge, D.
    Latran, M.
    Roe, D.
    Hage, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [36] Chronic lung allograft dysfunction phenotypes and treatment
    Verleden, Stijn E.
    Vos, Robin
    Vanaudenaerde, Bart M.
    Verleden, Geert M.
    JOURNAL OF THORACIC DISEASE, 2017, 9 (08) : 2650 - 2659
  • [37] Characterization Of Chronic Lung Allograft Dysfunction With Oscillometry
    Abelson, D.
    Vasileva, A.
    Matelski, J.
    Wu, J.
    Nadi, R.
    deHaas, E.
    Huang, Q.
    Martinu, T.
    Keshavjee, S.
    Cypel, M.
    Tikkanen, J.
    Ryan, C.
    Chow, C. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S56 - S56
  • [38] Fungal Prophylaxis and Chronic Lung Allograft Dysfunction
    Beach, S. L.
    Schaenman, J. M.
    Shino, Y. M.
    Ramsey, A.
    Saggar, R.
    Sayah, D. M.
    DerHovanessian, A.
    Lynch, J. P., III
    Ardehali, A.
    Belperio, J. A.
    Weigt, S. S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S303 - S304
  • [39] The Role of Galectins in Chronic Lung Allograft Dysfunction
    Miriana d’Alessandro
    Laura Bergantini
    Antonella Fossi
    Elda De Vita
    Felice Perillo
    Luca Luzzi
    Piero Paladini
    Piersante Sestini
    Paola Rottoli
    Elena Bargagli
    David Bennett
    Lung, 2021, 199 : 281 - 288
  • [40] Infectious Triggers of Chronic Lung Allograft Dysfunction
    Gregson, Aric L.
    CURRENT INFECTIOUS DISEASE REPORTS, 2016, 18 (07)